SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022.

Objectives. To assess the effectiveness of vaccine-induced immunity against new infections, all-cause emergency department (ED) and hospital visits, and mortality in Indiana. Methods. Combining statewide testing and immunization data with patient medical records, we matched individuals who received...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Public Health Vol. 113; no. 1; pp. 96 - 105
Autores principales: Tu, Wanzhu, Zhang, Pengyue, Roberts, Anna, Allen, Katie S., Williams, Jennifer, Embi, Peter, Grannis, Shaun
Formato: Artículo
Publicado: American Public Health Association Jan2023
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=160782931&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 160782931
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00900036
        APH
      jtl: American Journal of Public Health
      issn: 00900036
      maglogo: N
    pubinfo:
      dt: Jan2023
      vid: 113
      iid: 1
      pid: 44
      pub: American Public Health Association
    artinfo:
      ui:
        160782931
        10.2105/ajph.2022.307112
      ppf: 96
      ppct: 9
      formats:
      tig:
        atl: SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022.
      aug:
        au:
          Tu, Wanzhu
          Zhang, Pengyue
          Roberts, Anna
          Allen, Katie S.
          Williams, Jennifer
          Embi, Peter
          Grannis, Shaun
      su:
        Indiana
        Causes of death
        Immunization
        Hospital care
        Age groups
        Disease risk factors
        COVID-19
        Hospital emergency services
        Confidence intervals
        COVID-19 vaccines
        Reinfection
        Disease incidence
        Vaccine effectiveness
        Risk assessment
        Survival analysis (Biometry)
        Longitudinal method
        Algorithms
        Evaluation
      sug:
        subj:
          Causes of death
          Immunization
          Hospital care
          Age groups
          Disease risk factors
          Indiana
          COVID-19
          Hospital emergency services
          Confidence intervals
          COVID-19 vaccines
          Reinfection
          Disease incidence
          Vaccine effectiveness
          Risk assessment
          Survival analysis (Biometry)
          Longitudinal method
          Algorithms
          Evaluation
      ab: Objectives. To assess the effectiveness of vaccine-induced immunity against new infections, all-cause emergency department (ED) and hospital visits, and mortality in Indiana. Methods. Combining statewide testing and immunization data with patient medical records, we matched individuals who received at least 1 dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines with individuals with previous SARS-CoV-2 infection on index date, age, gender, race/ethnicity, zip code, and clinical diagnoses. We compared the cumulative incidence of infection, all-cause ED visits, hospitalizations, and mortality. Results. We matched 267 847 pairs of individuals. Six months after the index date, the incidence of SARS-CoV-2 infection was significantly higher in vaccine recipients (6.7%) than the previously infected (2.9%). All-cause mortality in the vaccinated, however, was 37% lower than that of the previously infected. The rates of all-cause ED visits and hospitalizations were 24% and 37% lower in the vaccinated than in the previously infected. Conclusions. The significantly lower rates of all-cause ED visits, hospitalizations, and mortality in the vaccinated highlight the real-world benefits of vaccination. The data raise questions about the wisdom of reliance on natural immunity when safe and effective vaccines are available. (Am J Public Health. 2023;113(1):96–104. https://doi.org/10.2105/AJPH.2022.307112)
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N